Endocrine Delivery System of NK4, an HGF-Antagonist and Anti-Angiogenic Regulator, for Inhibitions of Tumor Growth, Invasion and Metastasis

QR-Code

Endocrine Delivery System of NK4, an HGF-Antagonist and Anti-Angiogenic Regulator, for Inhibitions of Tumor Growth, Invasion and Metastasis

None

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Mizuno, Shinya, Nakamura, Toshikazu
Format:	Elektronisch Buchkapitel
Sprache:	Englisch
Veröffentlicht:	IntechOpen 2011
Schlagworte:	Physical Sciences, Engineering and Technology
Online-Zugang:	https://www.intechopen.com/chapters/25442
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Significance, Mechanisms, and Progress of Anticancer Drugs Targeting HGF-Met
von: Sakai, Katsuya, et al.
Veröffentlicht: (2011)

A Dual Role of HGF-ERK Signaling in IL6/HGF-induced Hepatocyte ProliferationSummary
von: Jingwei Zhang, et al.
Veröffentlicht: (2025-01-01)

Brain Tumor Stem Cells and Anti-Angiogenic Therapy
von: Saito, Katsuya, et al.
Veröffentlicht: (2011)

New Molecular Targets for Anti-Angiogenic Therapeutic Strategies
von: Linkous, Amanda G., et al.
Veröffentlicht: (2012)

Modified Maimendong Decoction Inhibits Lung Cancer Metastasis by Up-Regulating Levels of NK and CD8+ T Cells in Peripheral Blood and Tumor Microenvironment
von: Zhipeng ZHANG, et al.
Veröffentlicht: (2025-06-01)

The Role of HGF/c-Met Pathway Signaling in Human Medulloblastoma
von: Faria, Claudia, et al.
Veröffentlicht: (2011)

Anti-Angiogenic Therapy for Malignant Glioma: Insights and Future Directions
von: Province, Paula, et al.
Veröffentlicht: (2011)

ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
von: S. A. Korotkikh, et al.
Veröffentlicht: (2016-11-01)

Cooperative CCL2/CCR2 and HGF/MET signaling enhances breast cancer growth and invasion associated with metabolic reprogramming
von: Wei Fang, et al.
Veröffentlicht: (2025-12-01)

Gaillardin Impedes Human Ovarian Cancer Metastasis by Acting on Epithelial-Mesenchymal Transition and Angiogenic Factors
von: Sadegh Rajabi, et al.
Veröffentlicht: (2025-05-01)

GENETIC CRITERIA FOR ANTI-ANGIOGENIC THERAPY FOR TREATMENT OF DIABETIC MACULAR EDEMA
von: A. Z. Fursova, et al.
Veröffentlicht: (2019-02-01)

Aflatoxins: Mechanisms of Inhibition by Antagonistic Plants and Microorganisms
von: Razzaghi-Abyaneh, Mehdi, et al.
Veröffentlicht: (2011)

Unleashing the anti-tumor angiogenic potential of nano-formulated orientin: In Silico, In Vitro, and In Ovo studies.
von: Yashwanth Elumalai, et al.
Veröffentlicht: (2025-01-01)

Endometriosis and Angiogenic Factors
von: Artini, P. G., et al.
Veröffentlicht: (2012)

MINIMALLY INVASIVE METHODS OF SURGICAL TREATMENT OF ENDOCRINE OPHTHALMOPATHY
von: O. V. Levchenko, et al.
Veröffentlicht: (2017-07-01)

MicroRNA-34a inhibits tumor invasion and metastasis in osteosarcoma partly by effecting C-IAP2 and Bcl-2
von: Jie Wen, et al.
Veröffentlicht: (2017-06-01)

Quality of Animal Experiments in Anti-Angiogenic Cancer Drug Development--A Systematic Review.
von: Marianne Isabelle Martić-Kehl, et al.
Veröffentlicht: (2015-01-01)

Molecular Targets: Inhibition of Tumor Cell Invasion
von: Haga, Raquel Brandão, et al.
Veröffentlicht: (2012)

PATHOPHYSIOLOGICAL REASONING OF THE EFFICIENCY OF ANTI-ANGIOGENIC THERAPY IN THE RETINAL VEIN OCCLUSION BY THE COHERENT EYE TOMOGRAPHY
von: V. Yu. Mykhaylichenko, et al.
Veröffentlicht: (2018-05-01)

THE ROLE OF ANGIOGENIC GROWTH FACTORS IN MISCARRIAGES
von: Zh. A. Elzhorukaeva
Veröffentlicht: (2013-12-01)

Luteolin attenuates inflammation and apoptosis in LPS-induced ALI mice by activating the HGF/c-Met pathway
von: Jihong Bi, et al.
Veröffentlicht: (2025-07-01)

Reshaping the tumor microenvironment of cold soft-tissue sarcomas with anti-angiogenics: a phase 2 trial of regorafenib combined with avelumab
von: Maud Toulmonde, et al.
Veröffentlicht: (2025-06-01)

Anti-angiogenic effects of Moringa oleifera silver nanoparticles on endothelial cells: in vitro and ex vivo studies
von: Rolla Al-Shalabi, et al.
Veröffentlicht: (2025-07-01)

Pancreatic Cancer: Current Concepts in Invasion and Metastasis
von: Chiblak, Sara, et al.
Veröffentlicht: (2012)

Invasive lobular carcinoma of the breast with colonic metastasis: a case series of three patients
von: Shinya Otsuka, et al.
Veröffentlicht: (2023-10-01)

Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway.
von: Qing Ji, et al.
Veröffentlicht: (2013-01-01)

Inhibition of Tumor Growth and Metastasis by a Combination of Anti-VEGF-C and Enhanced IL-12 Therapy in an Immunocompetent Mouse Mammary Cancer Model
von: Shibata, Masa-Aki, et al.
Veröffentlicht: (2011)

The inhibiting effect of 357 bacteria and its antagonistic substance against powdery mildews
von: CHEN Xiao-xi, et al.
Veröffentlicht: (2002-07-01)

ANGIOGENIC BLOOD CELLS AFTER LIVER TRANSPLANTATION
von: A. N. Shutko, et al.
Veröffentlicht: (2012-12-01)

ANGIOGENIC PERACUTE SEPSIS IN AN HIV INFECTED PATIEN
von: L. V. Puzyreva, et al.
Veröffentlicht: (2018-01-01)

Upregulated Vav2 in gastric cancer tissues promotes tumor invasion and metastasis
von: Bi-bo Tan, et al.
Veröffentlicht: (2017-04-01)

Effect of Sulforaphane on Colon Cancer Cell Invasion and Metastasis
von: MA Yutong, JIAO Yingshuai, LIU Shuyu, WU Junjie, YU Wenlong, WANG Xianghong
Veröffentlicht: (2025-07-01)

Retraction: Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway.
von: PLOS One Editors
Veröffentlicht: (2025-01-01)

INHIBITION OF CELLULAR INVASION AND INDUCTION OF ANOIKIS IN MOUSE MELANOMA CELLS BY AN ANTI-INFLAMMATORY AGENT DTCM-GLUTARIMIDE
von: A. Kaneda, et al.
Veröffentlicht: (2017-01-01)

NK Cells in Health and Disease
von: Matthew D. Blunt
Veröffentlicht: (2025-05-01)

Intervention Potential of a Recombinant Tarim Red Deer HGF Protein in a Mouse Model of Alcoholic Liver Disease
von: Hong Chen, et al.
Veröffentlicht: (2025-06-01)

Apatinib for metastatic breast cancer in non-clinical trial setting: Satisfying efficacy regardless of previous anti-angiogenic treatment
von: Ying Lin, et al.
Veröffentlicht: (2017-06-01)

The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis.
von: David L Chan, et al.
Veröffentlicht: (2017-01-01)

Role of Inflammation and Angiogenic Growth Factors in Malignant Mesothelioma
von: Albonici, Loredana, et al.
Veröffentlicht: (2012)

Angiogenic Activity of the Peritoneal Mesothelium: Implications for Peritoneal Dialysis
von: Witowski, Janusz, et al.
Veröffentlicht: (2011)